rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Noubar Afeyan

Director

Company insider

Files Form 4 as: Director and 10% owner, Moderna; Director and 10% owner, Generate Biomedicines; 10% owner, Foghorn Therapeutics; 10% owner, Sana Biotechnology; Director and 10% owner, Omega Therapeutics; Director and 10% owner, Seres Therapeutics; Director and 10% owner, Rubius Therapeutics; Director and 10% owner, Evelo Biosciences.

Every Form 4 they filed

In numbers

Trades disclosed
532
Buys
7
Sells
100
Bought
$203.9M
Sold
$1.7B
Companies
19
Companies where not an officer
19
First trade
13 Jan 2005
Last trade
21 May 2026
Last filed
22 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MRNA ModernaDirector, 10% owner · Biotechnology · last 21 May 20260 buys · 94 sells
GENB Generate BiomedicinesDirector, 10% owner · Biotechnology · last 2 Mar 20262 buys · 0 sells
FHTX Foghorn Therapeutics10% owner · Biotechnology · last 22 May 20240 buys · 0 sells
SANA Sana Biotechnology10% owner · Biotechnology · last 12 Feb 20240 buys · 0 sells
Omega TherapeuticsDirector, 10% owner · last 7 Jun 20230 buys · 0 sells
MCRB Seres TherapeuticsDirector, 10% owner · Biotechnology · last 5 Jul 20222 buys · 0 sells
Rubius TherapeuticsDirector, 10% owner · last 12 May 20221 buy · 0 sells
Evelo BiosciencesDirector, 10% owner · last 12 Jun 20190 buys · 0 sells
TMDX TransMedics Group10% owner · Medical Devices · last 6 May 20190 buys · 0 sells
Kaleido BiosciencesDirector, 10% owner · last 4 Mar 20190 buys · 0 sells
Syros Pharmaceuticals10% owner · last 8 Sep 20170 buys · 0 sells
Eleven BiotherapeuticsDirector, 10% owner · last 15 Sep 20160 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
102Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 22 May 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$177K9,263 at $19.15filing
21 May 2026filed 22 May 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$434K9,263 at $46.84filing
21 May 2026filed 22 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—9,263 at $0.00filing
21 May 2026filed 22 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code M—9,263 at $0.00filing
21 May 2026filed 22 May 2026MRNA ModernaBiotechnologySEC FORM 4 Code M$177K9,263 at $19.15filing
21 May 2026filed 22 May 2026MRNA ModernaBiotechnologySEC FORM 4 Sold$434K9,263 at $46.84filing
6 May 2026filed 8 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—12,908 at $0.00filing
6 May 2026filed 8 May 2026MRNA Modernaoption or derivative · BiotechnologySEC FORM 4 Code A—12,908 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate BiomedicinesBiotechnologySEC FORM 4 Code C—12,723,940filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—18,483,785 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—17,016,215 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—1,500,000 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—843,881 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—1,265,822 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—2,953,586 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—2,109,704 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—2,531,644 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—1,265,822 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate Biomedicinesoption or derivative · BiotechnologySEC FORM 4 Code C—2,109,704 at $0.00filing
2 Mar 2026filed 2 Mar 2026GENB Generate BiomedicinesBiotechnologySEC FORM 4 Code C—13,702,224filing

The newest 500 lines are listed; the numbers count every line.

News

AI cannot replace clinical trials soon, warns Moderna co-founder Noubar Afeyanthehindubusinessline.com · 14 Oct 2026Moderna (NASDAQ:MRNA) Stock Price Down 17.6% – Here's WhyMRNA · dailypolitical.com · 24 Oct 2026Oncologists cheer melanoma data that tanked Moderna's sharesMRNA · spokesman.com · 24 Oct 2026Moderna Cancer Vaccine Data Confirms 42% Recurrence CutMRNA · financial-news.co.uk · 24 Oct 2026Generate Biomedicines to Participate in November Investor ConferencesGENB · manilatimes.net · 22 Oct 2026Zealand And Generate Biomedicines Team Up To Develop AI-Designed Therapies For Metabolic DiseasesGENB · rttnews.com · 14 Oct 2026Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic DiseasesGENB · manilatimes.net · 13 Oct 2026

1 headline in the last 90 days name Noubar Afeyan; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.

Sectors

Health Care99
Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Stephen HogePresident · President at Moderna, filing Form 4 there in the last year
James M. MockChief Financial Officer · Chief Financial Officer at Moderna, filing Form 4 there in the last year
Shannon Thyme KlingerChief Legal Officer · Chief Legal Officer at Moderna, filing Form 4 there in the last year
Frances ArnoldDirector · Director at Generate Biomedicines, filing Form 4 there in the last year
Stephane BancelChief Executive Officer · Chief Executive Officer at Moderna, filing Form 4 there in the last year
Maria Elvira SalazarRepresentative, FL-27 · Also traded MRNA in the last 90 days
Donald J. TrumpPresident · Also traded MRNA in the last 90 days
Eric D. ShaffDirector · Also traded MCRB in the last 90 days